The global vitamin B test market is expected to rise at a CAGR of 6.0% during the projected period. The market value is set to increase from USD 512.0 million in 2024 to USD 872.9 million in 2034.
Attributes | Key Insights |
---|---|
Anticipated Market Value in 2023 | USD 486.3 million |
Estimated Vitamin B Test Market Size (2024E) | USD 512.0 million |
Projected Vitamin B Test Market Value (2034F) | USD 872.9 million |
Value-based CAGR (2024 to 2034) | 6.0% |
The market for dietary supplements, particularly vitamin B supplements, has been driven by rising consumer awareness of the value of upholding a healthy lifestyle. Consumers are now actively looking for items that support general health and well-being due to the change toward preventative healthcare practices. Vitamin B supplements and tests are set to be frequently included in this trend.
To attract health-conscious consumers, manufacturers have added vitamin B to several functional foods & beverages, including energy drinks, fortified cereals, and nutritional bars. The increasing incidence of nutritionally influenced chronic diseases and disorders has sparked interest in vitamin B tests as a preventative healthcare strategy.
Global supply chains can impact the vitamin B test market, as key producers and distributors are dispersed throughout different parts of the globe. Vitamin B supplement production and marketing are affected by strict laws and quality standards in the food and pharmaceutical industries. Technological developments, such as better techniques for producing and extracting vitamins, can affect the price and accessibility of vitamin B products.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of vitamin B tests expanded at a CAGR of 5.0% from 2019 to 2023. The COVID-19 pandemic has positively affected the vitamin B test market and is expected to continue to do so in the forecast period.
The increasing diagnosis and treatment due to growing awareness & rising prevalence of health issues backed by vitamin B deficiency can increase the demand for the vitamin B test market. Extreme tiredness (fatigue), headaches, pale skin, loss of appetite, weight loss, noticeable heartbeats, lack of energy, breathlessness, and nausea are a handful of common symptoms of the deficiency of vitamin B in one’s body.
The advancement in vitamin B test kits and their easy availability would further drive the market’s growth. Different types of rapid vitamin B testing kits are available in the market through which tests can be conducted at home.
For instance, OmegaQuant launched a new vitamin B12 test, including a sample collection kit for testing at home.
It will likely present strong growth prospects for the market to multiply over the forecast period. Owing to the factors above, the global vitamin B test market is expected to rise at a CAGR of 6.0% during the forecast period from 2024 to 2034.
The growing prevalence of vitamin and folic acid deficiency is set to push the market’s growth in the forecast years. A poor diet and excessive alcohol consumption primarily bring on vitamin B deficiency. The increasing government healthcare efforts demonstrate the attractive market prospect for vitamin B tests.
For instance, the Government of India launched the Anaemia Mukt Bharat Program in March 2018 through the Ministry of Health and Family Welfare (MoHFW) to hasten the absence of anemia in different age groups by taking significant action.
During the foreseeable years, these factors would ensure lucrative opportunities for growth in the global vitamin B test market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below highlights the anticipated growth rates of different countries. Among these, India is expected to remain a lucrative vitamin B test market, exhibiting a CAGR of 10.3%. China and the United Kingdom are anticipated to follow with CAGRs of 5.5% and 4.8%, respectively.
Country | Value-based CAGR (2024 to 2034) |
---|---|
United States | 3.1% |
China | 5.5% |
Germany | 4.2% |
India | 10.3% |
United Kingdom | 4.8% |
The United States dominated North America’s vitamin B test market with a share of 86.7% in 2023. The country is expected to continue to experience the same growth rate throughout the forecast period. A handful of medical issues, such as celiac disease, Crohn's disease, or gastric bypass surgery, are becoming common and can affect vitamin absorption, especially vitamin B12.
Developments in diagnostic technologies are impacting the market for vitamin B tests in the United States. The market is expanding due to the need for more precise and effective testing procedures.
Market dynamics are influenced by the presence and actions of different companies operating in the diagnostic testing industry, especially those specializing in vitamin B tests. Due to the above-mentioned factors, demand for vitamin B testing in the United States is expected to surge by 2034.
Germany exhibited a share of 24.2% in Europe’s market in 2023.
India held a market share of 41.0% in 2023 across South Asia, with a total value of USD 24.52 million. The country is expected to continue to experience the same growth rate throughout the forecast period.
India has a significant number of vegetarian or vegan populations, which can increase the risk of vitamin B deficiencies in people. According to a review article by Truly Experiences 2022, there are a whopping 574 million people in India who are vegetarian. Vitamin B12, for example, is found predominantly in animal-based foods.
In India, people are becoming more proactive about tracking and improving their health. Hence, there is a growing emphasis on health and wellness.
There can also be a rise in the need for diagnostic testing, particularly those related to vital vitamins such as vitamin B. The trend toward preventative healthcare has increased the demand for diagnostic procedures that can detect nutritional deficits at an early stage.
The table below signifies leading sub-categories under product type, application, and end-user categories in the vitamin B test market. The folic acid (vitamin B9) test segment is expected to surge at a CAGR of 6.7% in the evaluation period. Under the application category, the high-performance liquid chromatography segment is projected to rise at a CAGR of 6.9% by 2034.
Product Type | Value CAGR |
---|---|
Vitamin B12 | 4.8% |
Folic Acid (Vitamin B9) Test | 6.7% |
The vitamin B12 segment held a significant market share of 43.2% in 2023. This segment is expected to increase with a CAGR of 4.8% during the forecast period. The rising prevalence of vitamin B12 deficiency globally is set to lead to the surging demand for vitamin B tests.
There is a tendency toward point-of-care testing (POCT) to increase the accessibility of diagnostic tests, including folic acid assays. POCT shortens the time it takes to diagnose a patient and makes timely treatments possible by enabling quick testing with results available at or close to the site of patient care.
The demand for folic acid tests among consumers has increased due to the growing awareness of the benefits of folic acid for prenatal care and general health. This is expected to further surge the segment at a CAGR of 6.7% by 2034.
Application | Value CAGR |
---|---|
ELISA | 5.4% |
High-performance liquid chromatography | 6.9% |
ELISA test held a prominent market share of 42.3% in the global market. Due to the simple procedure, high efficiency, sensitivity, and specificity, the ELISA test leads the market.
The precision and repeatability of high-performance liquid chromatography (HPLC) add to the dependability of vitamin B test findings. Applications in research, as well as clinical diagnostics, are dependent on high-performance liquid chromatography.
Modern HPLC systems with automation features increase productivity and lower the chance of human error. The frequent integration of data management systems and other analytical procedures makes workflow in the vitamin B testing process more accessible.
End-user | Value CAGR |
---|---|
Homecare Settings | 7.6% |
Diagnostic Centers | 6.2% |
Diagnostic centers had a significant market share of 33.4% of the total vitamin B test market. The segment is expected to rise at a CAGR of 6.2% from 2024 to 2034. Due to the increased diagnostic tests in laboratories worldwide, it is leading this market.
Convenient healthcare solutions are in great demand among customers. This need is met by convenient at-home vitamin B testing, which offers a hassle-free substitute for routine lab visits.
Regular nutritional status monitoring in the homecare setting can benefit those with chronic diseases such as pernicious anemia or certain gastrointestinal disorders that impair vitamin B levels. These factors are projected to drive the homecare setting segment by 2034.
There are several manufacturers in the vitamin B test market, which has resulted in a highly fragmented market. To meet consumer demand and expand their customer base, leading players are using growth strategies such as acquisitions, partnerships, collaborations, new product launches, and investments. Instances of key developmental strategies by industry players in the vitamin B test market are given below:
Attribute | Details |
---|---|
Estimated Vitamin B Test Market Size (2024) | USD 486.3 million |
Projected Vitamin B Test Market Revenue (2034) | USD 872.9 million |
Value-based CAGR (2024 to 2034) | 6.0% |
Forecast Period | 2019 to 2023 |
Historical Data Available for | 2024 to 2034 |
Market Analysis | USD million for Value |
Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa |
Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, GCC Countries, Türkiye, South Africa and North Africa |
Key Market Segments Covered | Product Type, Application, End-user, and Region |
Key Companies Profiled | ALPCO; Biohit Oyj; Boditech Med Inc.; EUROIMMUN Medizinische Labordiagnostika AG; Fujirebio; Optibio Co., Ltd.; Getein Biotech, Inc.; EagleBio; Everlywell, Inc.; LifeSpan BioSciences, Inc.; Biorbyt; Aviva Systems Biology Corporation; Abbexa Ltd.; Calbiotech; Cusabio Technology LLC; Cortez Diagnostics; Immundiagnostik ag; Bluecrest Wellness; Creative Diagnostics |
The market was valued at USD 486.3 million in 2023.
The market is expected to reach a valuation of USD 512.0 million in 2024.
The demand for vitamin B test is anticipated to rise at a 6.0% CAGR.
The vitamin B test market is projected to reach USD 872.9 million in 2034.
The homecare setting segment is expected to lead during the forecast period.
ALPCO, Biohit Oyj, and Boditech Med Inc. are the key players.
Rising prevalence of vitamin deficiency, technological advancements, and government initiatives.
1. Executive Summary 2. Market Overview 3. Market Trends and Dynamics 4. Value-Added Insights 5. Market Background 6. Global Market Demand Volume (Units) Analysis 2019 to 2023 and Forecast, 2024 to 2034 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in USD million) Analysis 2019 to 2023 and Forecast, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product 9.1. Vitamin B12 9.2. Folic Acid (Vitamin B9) Test 9.3. Others 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 10.1. ELISA 10.2. High-performance Liquid Chromatography 10.3. Lateral Flow Assay 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-user 11.1. Hospitals 11.2. Clinics 11.3. Homecare Settings 11.4. Diagnostic Centers 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 12.1. North America 12.2. Latin America 12.3. Europe 12.4. South Asia 12.5. East Asia 12.6. Oceania 12.7. Middle East and Africa 13. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 14. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 15. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 17. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 18. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034 19. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034 20. Market Structure Analysis 21. Competition Analysis 21.1. ALPCO 21.2. Biohit Oyj 21.3. Boditech Med Inc. 21.4. EUROIMMUN Medizinische Labordiagnostika AG 21.5. Fujirebio 21.6. Optibio Co., Ltd. 21.7. Getein Biotech, Inc. 21.8. EagleBio 21.9. Everlywell, Inc. 21.10. LifeSpan BioSciences, Inc. 21.11. Biorbyt 21.12. Aviva Systems Biology Corporation 21.13. Abbexa Ltd. 21.14. Calbiotech 21.15. Cusabio Technology LLC 21.16. Cortez Diagnostics 21.17. Immundiagnostik AG 21.18. Bluecrest Wellness 21.19. Creative Diagnostics 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports